Skip to main content
UniHealth

Doctor search

Erin H Amerson, MD

Dermatology · San Francisco

NPI 1679732671

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
12
2 carriers
Offices
2
Since medical school
22 years
Medical College of Wisconsin, 2004

Offices

2 locations · UCSF Medical Group Business Services · University of California Sfgh Medical Group

Looking this up.

Hospitals listed: UCSF Medical Center · Zuckerberg San Francisco General Hosp & Trauma Ctr. That is not proof they admit you there this week.

Plans that list them

12 plans · 2 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Amerson’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

12 of 12 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Imperial Courage Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Dynamic Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Senior Value (HMO C-SNP)Imperial Health Plan of California, Inc.ListedSep 1, 2026

California Medical Board record

Licence A105532 · Current

Licensed to practise in California · since 2008 · expires 2028-03-31 · Medical College of Wisconsin.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

School, training and certification

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

  • American Board of Dermatology - Dermatology

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend it
    Overall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
  • Zuckerberg San Francisco General Hosp & Trauma CtrSan Francisco, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of San Francisco Health Network, which runs 2 hospitalsPatients rate it 3 of 5 · 72% would definitely recommend it
    Overall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.449, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.37, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.538, Oct 2024 – Sep 2025
See every measure and the patient survey for UCSF Medical Center

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at UCSF Medical Center
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths4.9 (3.79 to 6.02) · 7,590 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits12.8 (11.3 to 14.4) · 2,019 casesWorseJan 2024 – Dec 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths139.4 (110.22 to 168.58) · 452 casesBetterJul 2022 – Jun 2024
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.622BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.626BetterOct 2024 – Sep 2025
MRSA BacteremiaInfections0.491BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.8 (0.7 to 1) · 2,336 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.24 (0.58 to 1.9) · 4,689 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.05 (0.89 to 1.2)No differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.9 · 89 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.5 · 85 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10.1 · 132 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.6 · 454 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 618 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.6 · 380 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.7 · 5,000 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.22 (0.06 to 0.38) · 15,965 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.2 (0.05 to 0.35) · 17,859 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.85 (0 to 1.83) · 4,184 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2 (1.1 to 2.9) · 6,516 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths7.35 (4.49 to 10.21) · 3,989 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5 (3.22 to 6.77) · 4,087 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.95 (0.74 to 3.15) · 2,034 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.95 (0.63 to 1.28) · 15,431 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 399 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.899No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.689No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.224No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16 · 156 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20 · 564 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits60.3 · 160 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-9.7 · 550 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits44.1 · 660 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.8 · 667 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.7 (4.8 to 6.7) · 2,019 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits6 · 421 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.5 · 53 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20 · 107 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.9 (11.3 to 17.1) · 3,247 casesNo differentJan 2022 – Dec 2024

What patients said (3,181 patients answered, 25% of those asked)

Patient survey stars by topic at UCSF Medical Center
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at UCSF Medical Center
Room was "always" clean71%
Nurses "always" communicated well80%
Doctors "always" communicated well80%
Staff "always" explained61%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge87%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)76%
Staff "always" explained new medications75%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully78%
Nurses "always" treated them with courtesy and respect86%
"Always" quiet at night50%
"YES", patients would definitely recommend the hospital81%
Staff "always" explained possible side effects46%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Zuckerberg San Francisco General Hosp & Trauma Ctr

Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 1 worse of 7 measures. Readmissions: 0 better, 7 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Zuckerberg San Francisco General Hosp & Trauma Ctr
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.449BetterOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.37BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.538BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.9 (0 to 1.91) · 667 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.12 (0.76 to 1.49)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths195.34 (147.34 to 243.34) · 76 casesNo differentJul 2022 – Jun 2024
Death rate for COPD patientsComplications and deaths7.2 · 114 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.2 · 48 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths7.5 · 201 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths14.5 · 214 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.3 · 261 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.5 · 1,351 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.29 (0.07 to 0.5) · 4,709 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.39 (0.19 to 0.59) · 4,644 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths4.34 (2.11 to 6.56) · 795 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.59 (0 to 3.28) · 234 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.85 (1.33 to 4.38) · 861 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.95 (0.25 to 17.64) · 261 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths6 (2.01 to 9.98) · 242 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.66 (0.17 to 3.14) · 167 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.79 (0.08 to 1.49) · 4,129 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.4 · 35 casesNoneApr 2023 – Mar 2025
MRSA BacteremiaInfections0.709No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.769No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits14.7 · 41 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits22.1 · 227 casesNoneJul 2023 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits28.6 · 257 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits75.1 · 239 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits18.2 · 232 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 175 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits11.3 (8.3 to 15.1) · 175 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits6.1 · 37 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20.2 · 132 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.6 (10.4 to 17.9) · 966 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1.2 (0.8 to 1.7) · 88 casesNo differentJan 2024 – Dec 2024

What patients said (1,644 patients answered, 16% of those asked)

Patient survey stars by topic at Zuckerberg San Francisco General Hosp & Trauma Ctr
Cleanliness4
Nurse communication2
Doctor communication3
Communication about medicines2
Discharge information3
Overall hospital rating4
Quietness3
Recommend hospital4
Share of patients giving the best answer at Zuckerberg San Francisco General Hosp & Trauma Ctr
Room was "always" clean69%
Nurses "always" communicated well73%
Doctors "always" communicated well75%
Staff "always" explained56%
Yes, staff "did" give patients this information84%
Yes, staff "did" give patients information about help after discharge83%
Doctors "always" explained things so they could understand68%
Doctors "always" listened carefully75%
Doctors "always" treated them with courtesy and respect82%
Patients who gave a rating of "9" or "10" (high)72%
Staff "always" explained new medications67%
Nurses "always" explained things so they could understand68%
Nurses "always" listened carefully70%
Nurses "always" treated them with courtesy and respect80%
"Always" quiet at night55%
"YES", patients would definitely recommend the hospital72%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms84%

Original Medicare doctor bills

$70,634

Medicare paid this office $70,634 for 210 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Return visit (30+ min)125$18,913$110
Destruction of skin growth, 1-14 growths98$14,928$111
Short return visit (20+ min)104$9,949$78
Destruction of precancer skin growth, 1 growth96$5,923$44
Destruction of precancer skin growth, 15 or more growths20$5,708$159
See all 10 services
Every Original Medicare service billed
Return visit (30+ min)125$18,913$110
Destruction of skin growth, 1-14 growths98$14,928$111
Short return visit (20+ min)104$9,949$78
Destruction of precancer skin growth, 1 growth96$5,923$44
Destruction of precancer skin growth, 15 or more growths20$5,708$159
Biopsy of related skin growth, first growth44$4,019$76
Destruction of precancer skin growth, 2-14 growths82$3,692$7
New patient visit (45+ min)12$1,722$144
Biopsy of related skin growth, each additional growth15$1,328$51
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's13$236$13

Procedures Medicare counted

Procedure volume Medicare published
Melanoma (skin cancer) excision1-10None
Removal of skin lesions473More than 86% of doctors who do this
Removal or shaving of skin growth1-10None
Skin biopsy64More than 71% of doctors who do this

Procedures year by year

Procedures billed to Original Medicare by year
Procedure201920202021202220232024
Destruction of precancer skin growth, 2-14 growths132122256399480552
Destruction of precancer skin growth, 1 growth44396991114135
Destruction of skin growth, 1-14 growths3829507284135
Biopsy of related skin growth, first growth271724444853
Destruction of precancer skin growth, 15 or more growths–––143536
Biopsy of related skin growth, each additional growth––––1626

Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.

Who their Medicare patients are

210 Original Medicare patients in 2024. Average age 74 · Under 65 6% · 85 and older 6% · Women 63% · Also on Medicaid 11% · Health risk score 0.99. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.

Conditions among them: High blood pressure 56% · Cancer 20% · Coronary heart disease 18% · Depression 17% · Diabetes 14% · Chronic kidney disease 14% · Atrial fibrillation 11% · Heart failure 6% · COPD 6%.

The office billed $442,603, Medicare allowed $96,272 and paid $70,634; for 1,332 services of 28 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20242101,332740.99$442,603$70,634
20232091,133741.03$378,650$61,008
2022205970740.98$316,821$50,666
2021141647721.00$211,729$34,046
2020112407711.33$129,821$19,282
2019115471701.32$164,031$24,741
201889345721.56$116,279$13,525
201751300731.30$74,471$6,698
201657313711.28$87,079$8,168
201554327691.53$79,430$7,479
201452216700.99$52,244$4,700
201345214731.02$48,853$5,081

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 10 services

Original Medicare services billed in 2023
Return visit (30+ min)123$18,843$111
Destruction of skin growth, 1-14 growths72$9,178$109
Short return visit (20+ min)62$5,634$77
Destruction of precancer skin growth, 15 or more growths23$5,611$160
Destruction of precancer skin growth, 1 growth94$5,021$44
Biopsy of related skin growth, first growth41$4,200$87
Destruction of precancer skin growth, 2-14 growths72$3,163$7
New patient visit (45+ min)18$2,463$137
Biopsy of related skin growth, each additional growth11$829$52
Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes15$262$12

2022: 10 services

Original Medicare services billed in 2022
Return visit (30+ min)97$13,694$110
Destruction of skin growth, 1-14 growths65$7,945$110
Short return visit (20+ min)66$5,626$74
Biopsy of related skin growth, first growth40$3,939$90
Destruction of precancer skin growth, 1 growth78$3,852$42
New patient visit (45+ min)25$3,325$133
Destruction of precancer skin growth, 2-14 growths62$2,571$6
Destruction of precancer skin growth, 15 or more growths13$2,365$169
New patient visit (30+ min)21$1,987$95
Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes22$316$14

2021: 8 services

Original Medicare services billed in 2021
Short return visit (20+ min)71$6,698$76
Return visit (30+ min)35$5,784$116
Destruction of skin growth, 1-14 growths41$5,035$101
New patient visit (30+ min)33$3,237$98
Destruction of precancer skin growth, 1 growth58$3,008$44
Biopsy of related skin growth, first growth21$2,017$84
New patient visit (45+ min)11$1,649$150
Destruction of precancer skin growth, 2-14 growths47$1,593$6

2020: 6 services

Original Medicare services billed in 2020
Short return visit (20+ min)66$6,047$64
Destruction of skin growth, 1-14 growths24$3,075$106
New patient visit (15+ min)29$1,605$55
Destruction of precancer skin growth, 1 growth32$1,405$36
Biopsy of related skin growth, first growth15$1,332$78
Destruction of precancer skin growth, 2-14 growths25$689$6

2019: 6 services

Original Medicare services billed in 2019
Short return visit (20+ min)65$7,300$68
Destruction of skin growth, 1-14 growths30$3,776$99
New patient visit (15+ min)44$2,696$61
Biopsy of related skin growth, first growth24$2,211$82
Destruction of precancer skin growth, 1 growth37$1,913$43
Destruction of precancer skin growth, 2-14 growths27$690$5

2018: 6 services

Original Medicare services billed in 2018
Short return visit (20+ min)47$3,315$47
Destruction of skin growth, 1-14 growths22$1,956$72
New patient visit (15+ min)31$1,880$61
Biopsy of single growth of skin and/or tissue18$1,177$62
Destruction of precancer skin growth, 1 growth24$1,000$37
Destruction of precancer skin growth, 2-14 growths18$318$3

2017: 5 services

Original Medicare services billed in 2017
Short return visit (20+ min)36$2,073$41
Destruction of skin growth, 1-14 growths16$1,309$62
Destruction of precancer skin growth, 1 growth23$1,005$35
Biopsy of single growth of skin and/or tissue12$290$24
Destruction of precancer skin growth, 2-14 growths20$271$2

2016: 6 services

Original Medicare services billed in 2016
Short return visit (20+ min)42$2,652$43
Destruction of skin growth, 1-14 growths17$1,154$61
Destruction of precancer skin growth, 1 growth24$1,135$34
New patient visit (15+ min)17$678$40
Biopsy of single growth of skin and/or tissue17$558$28
Destruction of precancer skin growth, 2-14 growths18$212$2

2015: 6 services

Original Medicare services billed in 2015
Short return visit (20+ min)41$2,617$40
Destruction of skin growth, 1-14 growths17$1,209$67
Destruction of precancer skin growth, 1 growth19$1,079$37
New patient visit (15+ min)13$535$41
Biopsy of single growth of skin and/or tissue12$468$28
Destruction of precancer skin growth, 2-14 growths18$272$2

2014: 4 services

Original Medicare services billed in 2014
Short return visit (20+ min)41$1,966$41
Destruction of precancer skin growth, 1 growth16$633$35
Biopsy of single growth of skin and/or tissue13$361$28
Destruction of precancer skin growth, 2-14 growths16$176$2

2013: 5 services

Original Medicare services billed in 2013
Short return visit (20+ min)27$1,259$32
Destruction of precancer skin growth, 1 growth17$815$39
Biopsy of single growth of skin and/or tissue14$352$25
Destruction of precancer skin growth, 2-14 growths16$340$4
New patient visit (15+ min)12$218$18

Medicaid work

$508,398 in 2024

Medicaid paid $508,398 for 3,378 billed services this clinician did in 2024, up to 119 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Clinic visit/encounter, all-inclusive1,493$505,945
Short return visit (20+ min)386$1,225
Return visit (30+ min)297$742
Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, single dose14$364
New patient visit (30+ min)28$81
Short return visit15$41
Actinotherapy (ultraviolet light)327$0
Interprofessional telephone/Internet/electronic health record assessment and management service provided by a consultative physician or other qualified health care professional, including a written report to the patient's treating/requesting physician or other qualified health care professional, 5 minutes or more of medical consultative time29$0
Service789$0
Medicaid work by year
20243,3789119$508,398
20233,008998$314,899
20222,573698$248,975
20212,799498$296,940
20201,630486$201,344
20197873104$193,107
20181,4212154$371,333
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Clinic visit/encounter, all-inclusive969$313,601
Short return visit (20+ min)662$761
Return visit (30+ min)374$538
Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug13$0
New patient visit (30+ min)26$0
OFF/OP EST MAY X REQ PHY/QHP13$0
Short return visit12$0
Interprofessional telephone/Internet/electronic health record assessment and management service provided by a consultative physician or other qualified health care professional, including a written report to the patient's treating/requesting physician or other qualified health care professional, 5 minutes or more of medical consultative time89$0
Service850$0

2022

Largest Medicaid services in 2022
Clinic visit/encounter, all-inclusive776$247,481
Short return visit (20+ min)1,005$1,337
New patient visit (30+ min)40$156
Return visit (30+ min)27$0
Interprofessional telephone/Internet/electronic health record assessment and management service provided by a consultative physician or other qualified health care professional, including a written report to the patient's treating/requesting physician or other qualified health care professional, 5 minutes or more of medical consultative time43$0
Service682$0

2021

Largest Medicaid services in 2021
Clinic visit/encounter, all-inclusive940$293,993
Short return visit (20+ min)1,025$2,713
Short return visit98$234
Service736$0

2020

Largest Medicaid services in 2020
Clinic visit/encounter, all-inclusive667$200,669
Short return visit (20+ min)553$667
OFF/OP EST MAY X REQ PHY/QHP28$8
Service382$0

2019

Largest Medicaid services in 2019
Clinic visit/encounter, all-inclusive639$192,878
Short return visit (20+ min)83$230
Service65$0

2018

Largest Medicaid services in 2018
Clinic visit/encounter, all-inclusive1,226$370,430
Short return visit (20+ min)195$903

Drugs they prescribed that Part D paid

$2,954,961

Pharmacies billed $2,954,961 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 1,555) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.

1,128 generic and fewer than 11 brand-name prescriptions · $2,954,961 in drug cost · 55 antibiotic prescriptions to 19 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Skyrizi24$439,228$18,301
Dupixent102$355,737$3,488
Humira(Cf)26$331,825$12,762
Humira35$308,468$8,813
Cosentyx Sensoready (2 Pens)19$178,280$9,383
See all 41 drugs
Every Part D drug this clinician prescribed
Skyrizi24$439,228$18,301
Dupixent102$355,737$3,488
Humira(Cf)26$331,825$12,762
Humira35$308,468$8,813
Cosentyx Sensoready (2 Pens)19$178,280$9,383
Dupixent50$171,068$3,421
Taltz15$97,356$6,490
Otezla13$60,694$4,669
Siliq11$54,808$4,983
Opzelura18$52,422$2,912
Zoryve13$11,153$858
Tacrolimus35$5,443$156
Acitretin11$4,698$427
Ketoconazole178$3,792$21
Clobetasol Propionate72$3,251$45
Fluocinonide55$2,669$49
Calcipotriene15$2,291$153
Triamcinolone Acetonide135$2,249$17
Fluorouracil29$2,198$76
Metronidazole31$1,522$49
Betamethasone Dipropionate42$1,457$35
Methotrexate61$1,035$17
Fluocinolone Acetonide12$937$78
Betamethasone Diprop Augmented11$847$77
Clindamycin15$843$56
Fluocinolone Acetonide12$713$59
Cephalexin18$609$34
Doxycycline Hyclate17$605$36
Clindamycin Phosphate19$429$23
Minoxidil48$403$8
Spironolactone23$398$17
Mycophenolate Mofetil11$396$36
Econazole Nitrate14$375$27
Hydroxyzine19$327$17
Hydroxychloroquine Sulfate11$316$29
Hydrocortisone62$286$5
Clotrimazole15$242$16
Mupirocin29$237$8
Dutasteride14$228$16
Terbinafine22$216$10
Prednisone20$68$3

Year by year

Part D prescribing by year
20241,5553640% (0)None$2,954,961
20231,6313560% (0)25%$3,836,038
20221,3423270% (0)19%$2,706,269
20211,0862760% (0)14%$1,262,034
20201,0772760% (0)11%$567,580
20191,3283390% (0)12%$844,117
20181,1522830% (0)None$494,241
20176912110% (0)8%$125,726
20167892190% (0)10%$217,762
2015335107NoneNone$76,172
2014262990% (0)None$32,361
2013205820% (0)None$14,904

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 38 drugs

Part D drugs prescribed in 2023
Humira(Cf)None78$837,964$10,743
GammakedImmune globulin13$615,207$47,324
HumiraNone47$528,838$11,252
SkyriziNone20$431,088$21,554
DupixentNone101$386,653$3,828
Cosentyx Sensoready (2 Pens)None20$219,874$10,994
StelaraNone15$214,957$14,330
DupixentNone29$117,124$4,039
Clobetasol PropionateNone71$13,363$188
AcitretinNone13$9,710$747
TacrolimusNone38$9,056$238
FluocinonideNone98$8,009$82
CalcipotrieneNone19$6,207$327
EntecavirNone17$6,066$357
Doxycycline HyclateNone32$5,240$164
KetoconazoleNone173$4,356$25
Halobetasol PropionateNone30$3,919$131
Triamcinolone AcetonideNone141$3,239$23
Betamethasone DipropionateNone36$2,575$72
MethotrexateNone67$2,521$38
FluorouracilNone23$2,123$92
MetronidazoleNone24$1,875$78
Mycophenolate MofetilNone19$1,766$93
Hydroxychloroquine SulfateNone15$1,067$71
Betamethasone Diprop AugmentedNone22$1,016$46
Clindamycin PhosphateNone20$896$45
HydrocortisoneNone85$833$10
Sulfamethoxazole-TrimethoprimNone12$533$44
ValacyclovirNone13$533$41
Econazole NitrateNone13$511$39
ClotrimazoleNone16$485$30
SpironolactoneNone20$481$24
TerbinafineNone11$454$41
HydroxyzineNone17$434$26
GabapentinNone12$413$34
MinoxidilNone26$343$13
MupirocinNone23$276$12
PrednisoneNone22$225$10

2022: 29 drugs

Part D drugs prescribed in 2022
HumiraNone30$689,565$22,986
GammakedImmune globulin16$508,078$31,755
Humira(Cf)None59$467,010$7,915
StelaraNone22$301,435$13,702
Cosentyx Pen (2 Pens)None12$150,665$12,555
DupixentNone27$95,278$3,529
Clobetasol PropionateNone86$10,600$123
FluocinonideNone128$9,552$75
AcitretinNone16$9,322$583
EntecavirNone14$7,970$569
TacrolimusNone31$6,907$223
Halobetasol PropionateNone39$5,412$139
Betamethasone DipropionateNone56$4,896$87
KetoconazoleNone111$3,032$27
Doxycycline HyclateNone34$2,763$81
Triamcinolone AcetonideNone146$2,532$17
MetronidazoleNone21$1,765$84
Betamethasone Diprop AugmentedNone19$1,620$85
FluorouracilNone12$1,557$130
Clindamycin PhosphateNone29$1,539$53
Mycophenolate MofetilNone20$1,469$73
MethotrexateNone21$911$43
HydroxyzineNone22$598$27
ClotrimazoleNone21$579$28
HydrocortisoneNone67$568$8
Econazole NitrateNone13$471$36
SpironolactoneNone11$262$24
PrednisoneNone22$250$11
MupirocinNone13$109$8

2021: 24 drugs

Part D drugs prescribed in 2021
Humira12$301,658$25,138
Humira(Cf)29$233,817$8,063
Acitretin14$7,894$564
Fluocinonide101$6,325$63
Doxycycline Hyclate21$4,845$231
Clobetasol Propionate64$4,640$73
Halobetasol Propionate37$4,356$118
Tacrolimus20$3,454$173
Betamethasone Dipropionate34$2,652$78
Mycophenolate Mofetil15$2,464$164
Triamcinolone Acetonide162$2,453$15
Ketoconazole92$2,103$23
Metronidazole23$1,662$72
Hydroxychloroquine Sulfate18$1,536$85
Betamethasone Diprop Augmented16$1,257$79
Econazole Nitrate23$826$36
Clindamycin Phosphate20$712$36
Methotrexate18$579$32
Valacyclovir13$539$41
Clotrimazole21$505$24
Hydrocortisone59$391$7
Spironolactone12$300$25
Hydroxyzine24$266$11
Prednisone14$122$9

2020: 22 drugs

Part D drugs prescribed in 2020
Dupixent20$63,600$3,180
Tacrolimus34$9,929$292
Halobetasol Propionate47$5,959$127
Fluocinonide83$5,696$69
Doxycycline Hyclate29$5,423$187
Clobetasol Propionate50$4,874$97
Tretinoin24$3,144$131
Ketoconazole134$2,885$22
Betamethasone Dipropionate25$2,692$108
Hydroxychloroquine Sulfate24$2,643$110
Triamcinolone Acetonide133$2,289$17
Fluorouracil13$1,717$132
Fluocinolone Acetonide12$1,593$133
Betamethasone Diprop Augmented20$1,580$79
Methotrexate37$1,311$35
Clindamycin Phosphate31$1,184$38
Metronidazole11$999$91
Clotrimazole25$654$26
Gabapentin44$473$11
Hydrocortisone65$467$7
Hydroxyzine17$150$9
Sulfamethoxazole-Trimethoprim12$86$7

2019: 30 drugs

Part D drugs prescribed in 2019
Humira(Cf)15$157,163$10,478
Humira14$153,359$10,954
Humira(Cf)15$78,690$5,246
Dupixent15$44,727$2,982
Halobetasol Propionate87$15,170$174
Tacrolimus41$9,808$239
Acitretin17$9,060$533
Fluocinonide93$8,020$86
Clobetasol Propionate42$7,158$170
Calcipotriene23$4,748$206
Betamethasone Diprop Augmented48$4,356$91
Fluocinolone Acetonide17$3,837$226
Econazole Nitrate11$3,818$347
Triamcinolone Acetonide172$3,459$20
Fluorouracil17$2,527$149
Metronidazole20$2,402$120
Ketoconazole105$2,211$21
Betamethasone Dipropionate19$1,829$96
Clindamycin Phosphate28$1,697$61
Mycophenolate Mofetil16$1,199$75
Methotrexate38$999$26
Doxycycline Monohydrate18$916$51
Gabapentin71$805$11
Clotrimazole40$784$20
Mometasone Furoate14$733$52
Prednisone40$489$12
Hydroxyzine31$450$15
Doxycycline Hyclate14$420$30
Hydrocortisone52$382$7
Mupirocin14$106$8

2018: 28 drugs

Part D drugs prescribed in 2018
Humira21$140,967$6,713
Humira21$115,651$5,507
Halobetasol Propionate84$14,760$176
Clobetasol Propionate43$8,977$209
Fluocinonide99$8,338$84
Acitretin16$8,159$510
Calcipotriene21$5,016$239
Tacrolimus21$4,908$234
Econazole Nitrate16$4,693$293
Ketoconazole92$3,801$41
Betamethasone Diprop Augmented39$3,695$95
Triamcinolone Acetonide159$3,368$21
Fluorouracil19$2,450$129
Methotrexate43$2,257$52
Clindamycin Phosphate25$2,063$83
Hydroxychloroquine Sulfate13$1,832$141
Mycophenolate Mofetil11$1,532$139
Metronidazole11$1,276$116
Doxycycline Hyclate17$1,147$67
Clotrimazole26$1,011$39
Alclometasone Dipropionate11$984$89
Hydroxyzine29$765$26
Hydrocortisone58$605$10
Prednisone34$358$11
Terbinafine12$291$24
Doxepin11$241$22
Gabapentin25$225$9
Sulfamethoxazole-Trimethoprim14$204$15

2017: 15 drugs

Part D drugs prescribed in 2017
Clobetasol Propionate46$12,228$266
Calcipotriene24$9,512$396
Fluocinonide75$8,162$109
Halobetasol Propionate41$7,912$193
Fluorouracil19$7,430$391
Ketoconazole69$3,094$45
Econazole Nitrate20$2,328$116
Triamcinolone Acetonide92$1,641$18
Clindamycin Phosphate25$1,533$61
Alclometasone Dipropionate15$1,326$88
Clotrimazole16$574$36
Hydrocortisone38$371$10
Methotrexate12$288$24
Prednisone16$206$13
Mupirocin13$160$12

2016: 18 drugs

Part D drugs prescribed in 2016
Clobetasol Propionate105$28,650$273
Fluocinonide108$11,071$103
Fluorouracil12$9,491$791
Calcipotriene19$7,037$370
Econazole Nitrate24$3,061$128
Metronidazole19$2,721$143
Clindamycin Phosphate25$1,911$76
Doxycycline Hyclate11$1,699$154
Triamcinolone Acetonide83$1,640$20
Tretinoin18$1,084$60
Alclometasone Dipropionate13$977$75
Ketoconazole39$878$23
Clotrimazole16$704$44
Hydrocortisone70$647$9
Methotrexate12$417$35
Prednisone27$414$15
Hydroxyzine13$166$13
Mupirocin16$120$8

2015: 8 drugs

Part D drugs prescribed in 2015
Clobetasol Propionate35$9,291$265
Econazole Nitrate16$4,264$267
Fluocinonide35$3,737$107
Desonide19$3,626$191
Clindamycin Phosphate16$1,501$94
Triamcinolone Acetonide27$460$17
Prednisone15$133$9
Hydrocortisone11$69$6

2014: 9 drugs

Part D drugs prescribed in 2014
Clobetasol Propionate17$2,594$153
Econazole Nitrate35$2,428$69
Fluocinonide33$2,213$67
Desonide11$2,121$193
Fluocinolone Acetonide11$1,900$173
Doxycycline Hyclate13$1,535$118
Clindamycin Phosphate17$1,185$70
Triamcinolone Acetonide29$540$19
Hydrocortisone14$138$10

2013: 8 drugs

Part D drugs prescribed in 2013
Clobetasol Propionate34$1,916$56
Fluocinonide21$1,296$62
Desonide21$1,208$58
Doxycycline Hyclate11$727$66
Econazole Nitrate15$382$25
Triamcinolone Acetonide22$315$14
Hydroxyzine11$293$27
Hydrocortisone12$83$7

Money from drug and device companies

$74 in 2025

A payment is not proof that care is biased.

Payments by company
PfizerCibinqo$74
1 payment
  • Meals for Cibinqo · 2025-03-07 · $74
See the published payment
Every published payment
PfizerMeals · 2025-03-07Cibinqo$74

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
91.9 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1679732671
Licence
CA A105532California A105532: Current · expires 2028-03-31
Trained
Medical College of Wisconsin, 2004 · 22 years ago
Group
UCSF Medical Group Business Services · University of California Sfgh Medical Group
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207N00000X (207N00000X)
Mailing address
1701 Divisadero St, 3rd Floor, San Francisco, CA, 94115
NPI first listed
2008-06-04
NPI last updated
2012-02-29

This is when the NPI record was last certified, not a medical board exam.